On the afternoon of December 18th, Psychstocks announced BetterLife Pharma (CSE: BETR) at $1.17 per share as its #1 favorite Psychstock for 2021. BETR closed today at its high of day of $2.25 per share. BETR has already gained by 92.3% in only seven trading days!
Prior to BETR, our previous two #1 favorite Psychstocks Numinus Wellness (TSXV: NUMI) and Revive Therapeutics (CSE: RVV) gained by 807.41% and 275.51%, respectively!
We consider BETR to be the best positioned psychedelic company to capitalize on the therapeutic potential of LSD! BETR has more catalysts ahead in 2021 than any other Psychstock we follow!
Past performance is not an indicator of future returns. Psychstocks is not an investment advisor and does not provide investment advice. Always do your own research and make your own investment decisions. This message is not a solicitation or recommendation to buy, sell, or hold securities. The parent company of Psychstocks has been compensated by BETR US$50,000 cash and expects to receive an additional US$50,000 worth of restricted BETR shares for a six-month marketing contract. The parent company of Psychstocks was previously compensated by BETR US$50,000 cash for a six-month marketing contract which has since expired. The parent company of Psychstocks has been compensated by NUMI USD$30,000 cash for a six-month marketing contract. The parent company of Psychstocks has been compensated by RVV USD$30,000 cash for a six-month marketing contract. This message is meant for informational and educational purposes only and does not provide investment advice.